Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5R,8S,11S,14S,17R,20S,23S,26R,29R,35R,38R,42R,45S)-26-((1H-indol-3-yl)methyl)-17,20,35-tris(2-aminoethyl)-14-benzyl-5-sec-butyl-11-(2-carboxyethyl)-42-hydroxy-23,29-bis(hydroxymethyl)-8,38-diisopropyl-2,45-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaazaheptatetracontan-1-oic acid
ID: ALA3115747
PubChem CID: 76332415
Max Phase: Preclinical
Molecular Formula: C73H115N17O20
Molecular Weight: 1550.82
Molecule Type: Unknown
Associated Items: